EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA AND ITS ASSOCIATION WITH BASELINE WHITE BLOOD CELL COUNT AND SPLEEN SIZE
Objectives: To determine the frequency of early molecular response in patients of chronic myeloid leukemia treated with Imatinib and its association with baseline white blood cell (WBC) count and spleen size. Study Design: Cross sectional study. Place and Duration of Study: Combined Military Hosp...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Army Medical College Rawalpindi
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/d08677138f37425ea0848e8e5bae5e9c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|